相似文献
1
The Evolution of Angiogenic and Inflamed Tumors: The Renal Cancer Paradigm.
Cancer Cell. 2020 Dec 14;38(6):771-773. doi: 10.1016/j.ccell.2020.10.021. Epub 2020 Nov 5.
2
Savolitinib for MET-driven papillary renal cell carcinoma.
Lancet Oncol. 2017 Aug;18(8):e440. doi: 10.1016/S1470-2045(17)30508-9. Epub 2017 Jun 29.
3
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type.
EBioMedicine. 2020 Jan;51:102526. doi: 10.1016/j.ebiom.2019.10.052. Epub 2019 Dec 16.
4
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.
Cancer Cell. 2020 Dec 14;38(6):803-817.e4. doi: 10.1016/j.ccell.2020.10.011. Epub 2020 Nov 5.
5
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors.
Clin Genitourin Cancer. 2019 Oct;17(5):e981-e994. doi: 10.1016/j.clgc.2019.05.009. Epub 2019 May 25.
6
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Lancet Oncol. 2018 Dec;19(12):1688-1698. doi: 10.1016/S1470-2045(18)30648-X. Epub 2018 Nov 8.
7
MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017 Nov 22;18(11):2495. doi: 10.3390/ijms18112495.
8
Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer.
J Clin Oncol. 2005 Jan 20;23(3):410-2. doi: 10.1200/JCO.2005.09.907. Epub 2004 Nov 30.
9
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Int J Mol Sci. 2021 Mar 11;22(6):2832. doi: 10.3390/ijms22062832.
10
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
J Urol. 2008 Sep;180(3):860-5; discussion 865-6. doi: 10.1016/j.juro.2008.05.015. Epub 2008 Jul 17.
引用本文的文献
1
AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma.
Cell Rep Med. 2025 Aug 19;6(8):102299. doi: 10.1016/j.xcrm.2025.102299.
2
Machine learning-based single-sample molecular classifier for cancer grading.
Front Oncol. 2025 Jul 16;15:1617898. doi: 10.3389/fonc.2025.1617898. eCollection 2025.
3
Renal cell carcinoma with metastasis to the pancreas: a model for oligometastasis, oligoprogression and metastatic organotropism.
Clin Exp Metastasis. 2025 Jul 3;42(4):38. doi: 10.1007/s10585-025-10359-w.
4
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial.
Nat Commun. 2025 Mar 17;16(1):2610. doi: 10.1038/s41467-025-57717-6.
5
Determinants of late metastases in renal cell carcinoma.
J Natl Cancer Inst. 2025 Jul 1;117(7):1387-1400. doi: 10.1093/jnci/djaf060.
6
Conserved patterns of transcriptional dysregulation, heterogeneity, and cell states in clear cell kidney cancer.
Cell Rep. 2025 Jan 28;44(1):115169. doi: 10.1016/j.celrep.2024.115169. Epub 2025 Jan 9.
7
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial.
ArXiv. 2024 May 28:arXiv:2405.18327v1.
8
Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity.
Cancers (Basel). 2024 Feb 19;16(4):829. doi: 10.3390/cancers16040829.
9
Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis.
Immunooncol Technol. 2023 Nov 22;21:100690. doi: 10.1016/j.iotech.2023.100690. eCollection 2024 Mar.
10
Tumor-to-Tumor Metastases Involving Clear Cell Renal Cell Carcinomas: A Diagnostic Challenge for Pathologists Needing Clinical Correlation.
Clin Pract. 2023 Feb 16;13(1):288-296. doi: 10.3390/clinpract13010026.
本文引用的文献
1
What morphology can teach us about renal cell carcinoma clonal evolution.
Kidney Cancer J. 2020 Sep;18(3):68-76.
2
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.
Cancer Cell. 2020 Dec 14;38(6):803-817.e4. doi: 10.1016/j.ccell.2020.10.011. Epub 2020 Nov 5.
3
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors.
Cancer Discov. 2018 Sep;8(9):1142-1155. doi: 10.1158/2159-8290.CD-17-1246. Epub 2018 Jun 8.
4
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Nat Med. 2018 Jun;24(6):749-757. doi: 10.1038/s41591-018-0053-3. Epub 2018 Jun 4.
5
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12.
6
Modeling Renal Cell Carcinoma in Mice: and Inactivation Drive Tumor Grade.
Cancer Discov. 2017 Aug;7(8):900-917. doi: 10.1158/2159-8290.CD-17-0292. Epub 2017 May 4.
7
Cooperation and antagonism among cancer genes: the renal cancer paradigm.
Cancer Res. 2013 Jul 15;73(14):4173-9. doi: 10.1158/0008-5472.CAN-13-0360. Epub 2013 Jul 5.
8
Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature. 2013 Jul 4;499(7456):43-9. doi: 10.1038/nature12222. Epub 2013 Jun 23.
9
BAP1 loss defines a new class of renal cell carcinoma.
Nat Genet. 2012 Jun 10;44(7):751-9. doi: 10.1038/ng.2323.
10
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.
Genes Cancer. 2010 Feb 1;1(2):152-163. doi: 10.1177/1947601909359929.
Zotero 插件